Shripad Banavali

Homi Bhabha National Institute — India

Medicine · Health Sciences

34h-index6.2kcitations286works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(61), Acute Myeloid Leukemia Research(38), Lymphoma Diagnosis and Treatment(34), Childhood Cancer Survivors' Quality of Life(29), Chronic Lymphocytic Leukemia Research(29)

Publications285 total

Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers
Journal of Geriatric Oncology·2025
Hemodilution assessment for high-sensitivity flow cytometric measurable residual disease evaluation in pediatric B-cell acute lymphoblastic leukemia
Blood·2025Open Access
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)
JCO Global Oncology·2025· 2 citedOpen Access
Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India
Clinical Lymphoma Myeloma & Leukemia·2025· 1 cited
Vascular endothelial growth factor: A potential prognosticator in Ewing sarcoma
Indian Journal of Cancer·2025· 1 citedOpen Access
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
Blood Cancer Journal·2025· 7 citedOpen Access
Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes
Cancer Letters·2025· 1 cited
Prognostic Modeling for Bone Sarcomas Based on a Large Prospective Cohort From a Tertiary Care Cancer Center in India
JCO Global Oncology·2025Open Access
Metronomic Chemotherapy and Low-Dose Immunotherapy: An Intriguing Story
2025Open Access
Prevalence of hepatitis B and C in survivors of childhood cancer treated over five decades
Pediatric Hematology Oncology Journal·2025Open Access
Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial
British Journal of Cancer·2024· 3 citedOpen Access
Treatment‐Free Remissions in Children With Chronic Myeloid Leukemia (<scp>CML</scp>): A Prospective Study From the Tata Memorial Hospital (<scp>TMH</scp>) Pediatric <scp>CML</scp> (<scp>pCML</scp>) Cohort
American Journal of Hematology·2024· 7 citedOpen Access
Talicabtagene Autoleucel (humanized CD19 CAR-T) As a Second Line Therapy in r/r B-Cell Lymphoma: Sub-Analysis from a Phase I/II Trial
Blood·2024· 2 citedOpen Access
Myelodysplasia-Related Mutations in Adults and End-of-Induction Measurable Residual Disease Are Associated with Inferior Outcome in Patients with Acute Leukemia of Ambiguous Lineage
Blood·2024Open Access
Clinical Relevance and Applicability of the 2022 World Health Organization Classification of Childhood B Lymphoblastic Leukemia in the Context of MRD-Directed Therapy
2024Open Access
Phase <scp>III</scp> randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/ <scp>GEJ</scp> cancer
International Journal of Cancer·2024· 3 citedOpen Access
Under-representation of older Indian persons with cancer in clinical trials
BMJ Oncology·2024· 5 citedOpen Access
Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 Years
Journal of Gastrointestinal Cancer·2024Open Access
A phase III randomized, open-label study to establish the superiority of triple oral metronomic therapy (OMCT) used in addition to chemotherapy regimen (paclitaxel + carboplatin) over chemotherapy alone for the treatment of advanced unresectable head and neck cancer squamous cell cancer (HNSCC).
Journal of Clinical Oncology·2024· 2 cited
Acupuncture as a modality of treatment for chemotherapy-induced peripheral neuropathy in breast cancer: A phase 3 randomized controlled trial (ABC-CIPN).
Journal of Clinical Oncology·2024
page 1 of 15Next →

Frequent Co-authors

Kumar Prabhash(17), Vanita Noronha(13), Vijay Patil(13), Gaurav Narula(10), Amit Joshi(9), Maya Prasad(8), Nandini Menon(7), Atanu Bhattacharjee(7), Rajendra Badwe(6), Abhishek Mahajan(6), Sudeep Gupta(6), Arun Chandrasekharan(5), Kavita Nawale(5), Sachin Dhumal(5), Jaya Ghosh(5), Papagudi Ganesan Subramanian(5), Yajamanam Badrinath(5), Sumeet Gujral(5), Jyoti Bajpai(5), Tushar Vora(5)